cGMP - everything you need to know

michael-muehlegger

Michael Mühlegger

March 1, 2023

Table of contents

Show

The current Good Manufacturing Practice (cGMP) regulations - originated and checked by the FDA - apply to companies operating in pharmaceutical, biotech, or med tech industries. 

They require the latest standards in terms of production, manufacturing, and packaging and thereby ensure pharmaceutical quality meaning quality in biopharmaceutical processing and patient safety as the ultimate goal. The detailed guidelines, importance of cGMP, and how companies can best meet the cGMP regulations, are discussed in the following.

cGMP a definition

Current Good Manufacturing Practice, also known as cGMP, are a set of regulations that ensure the quality of pharmaceutical products, medical devices, biotechnology products, food and beverage, and dietary supplements. They therefore apply to all organizations involved in the manufacturing processes of these products.

To be compliant with the cGMP regulations, companies must meet the latest quality standards. These apply to buildings and facilities, equipment, production, process controls, laboratory controls, packaging and labeling, and returned or salvaged drug products.1 

cgmp

cGMP guidelines

cGMP compliance is monitored by the Food and Drug Administration (FDA). It sets the rules of CFR (Code of Federal Regulation) Title 21 based on the Federal Food, Drug and Cosmetic Act. The parts addressing the cGMP, list the minimum requirements of the production process from start to finish in order to ensure that the drug product has the identity, quality, strength and purity promised.2 

The cGMP guidelines are described in several parts of Title 21 and allow a good understanding of the regulatory process:
21 CFR Part 314: Applications for FDA Approval to Market a New Drug
21 CFR Part 210: cGMP for Manufacturing, Processing, Packing, or Holding of Drugs
21 CFR Part 211: cGMP for Finished Pharmaceuticals
21 CFR Part 212: cGMP for Positron Emission Tomography Drugs
21 CFR Part 600: Biological Products: General

The following three paragraphs will outline 21 CFR Part 210 in which most regulations revolve around requirements for staff, equipment, facilities, and the production process.

cGMP requirement 1: Staff

Especially for companies and organizations involved in drug manufacturing and therefore representing a key cGMP requirement, qualified and trained staff is crucial. The personnel must be appropriately qualified and trained and keep up-to-date with the latest training and knowledge relevant to their tasks. 

Current Good Manufacturing Practice (cGMP) regulations: an overview

cGMP requirement 2: Facilities & Equipment

To be compliant with cGMP regulations, pharmaceutical companies’ buildings and production facilities must be properly and thoroughly maintained to ensure safe and effective manufacturing conditions. Similarly, current Good Manufacturing Practices require organizations to have modern equipment that is conscientiously maintained and not outdated at any time. The same applies to the Standard Operating Procedures (SOP).

cGMP requirement 3: Process & Products

cGMP recommend that the processes used to manufacture pharmaceutical products involve the latest science and technology. In addition, it is crucial that a master formula is adhered to for each product throughout the manufacturing process without any deviations. 

What is GMP?

Like the cGMP, Good Manufacturing Practice (GMP) is part of quality assurance and ensures that companies involved in manufacturing, processing, and packaging drugs, medical devices, some sorts of food, and blood follow certain quality and effectiveness standards. Thereby they should eliminate or at least minimize any kind of contamination, mix-ups, or errors guaranteeing that customers purchase effective and safe products. They concern issues such as equipment verification, process validation, record keeping, and process improvements in form of standardization.

GMP guidelines are very general in nature, meaning that the manufacturers decide and interpret themselves how to best implement them in their business. However, they do have the force of law and can in some cases result in fines, recall, seizure, and jail time if failed to comply.

Since those regulations frequently change, the so-called current Good Manufacturing Practice (cGMP) is a more recent version of the GMP requiring companies to use technologies and systems that are up-to-date.3 

What is the difference between GMP and cGMP?

Seemingly no difference, the timeliness of the regulations results in differences between GMP and cGMP in terms of quality, cost, and standards:

  • Quality: While GMP covers the required standards of an industry, cGMP ensures that a company is following/applying the latest regulations.
  • Cost: Due to additional testing and state-of-the-art technologies, cGMP is more expensive to implement and maintain than GMP.
  • Standards: GMP regulations are the minimum standards required for pharmaceutical, biotech, medtech, and medical devices industries. With cGMP, on the other hand, companies make sure that they are compliant with the most recent rules and regulations applicable to their industry and also that each step was completed using the latest available methods
cgmp-gmp-difference

What is EU GMP Annex 1?

EU GMP Annex 1 is a regulatory guideline that sets standards for manufacturing sterile medicinal products. The guidelines are set by the European Medicines Agency (EMA) and FDA. It focuses on aseptic processing and contamination control to ensure product safety and quality. The annex covers various areas such as facility design, environmental monitoring, personnel training, and process validation. One significant aspect influenced by Annex 1 is the use of single-use assemblies in fluid management processes. It emphasizes the need for a risk-based approach to ensure the integrity and sterility of single-use systems used in closed systems for fluid management. Compliance with GMP Annex 1 is crucial for companies operating in the biopharmaceutical industry to meet regulatory requirements and maintain high-quality standards.

How is the FDA controlling cGMP compliance?

The FDA’s role is to first promulgate cGMP regulations and guidance documents and then to determine whether the quality of pharmaceutical products comply with those regulations. In doing so, trained FDA assessors and investigators inspect companies around the world to verify that the facilities, where active ingredients and finished pharmaceutical products are manufactured, meet the standards. Inspections follow a standard procedure and are often based on reports or concerns flagged by the public and the industry. If cGMP violations are found, the manufacturer should implement corrective and preventive actions as part of the overall quality management system.

Importance of cGMP compliance

Compliance with cGMP requirements assures end-users that products were manufactured in accordance with the most recent industry standards and are therefore pure, safe, and effective. It ensures:

  • Buildings and facilities in good condition
  • Correctly maintained and calibrated equipment
  • Reliable processes and procedures
  • Qualified and trained staff
  • Safe and high quality products

In order to fulfill the cGMP guidelines, pharmaceutical companies are heavily dependent on equipment suppliers.

Read more: Biopharma supply chain – 7 risks to be aware of

Meeting cGMP regulations with single-use technology

Companies that want to fill, freeze, and ship in a cGMP compliant manner, typically face several challenges. There is still a severe technology gap in the biopharmaceutical production that hinders manufacturers from standardizing and scaling the process. Single-use technologies in biopharmaceutical processing ensure greater safety, maintain drug substance quality, and are highly efficient and scalable. Fully automated single-use filling platforms like RoSS.FILL from Single Use Support enable standardization, which is crucial for meeting cGMP requirements.

Looking for real-time information about an active ingredient? Single Use Support’s Ultra Smart Tracking helps verify temperature, geo-position, air pressure and much more 24/7 during international shippings in adherence with 21 CFR Part 11.

Ultra-smart-tracking

Whitepaper: Automated Aseptic Filling

Automated Aseptic Filling Unprecedented flexibility to filling well

Read more about cGMP regulations

IRIS Single-Use Assmeblies_Production Kufstein-9

Navigating GMP Annex 1: How Single-Use Assemblies will Comply

GMP Annex 1 significantly impacts the use of single-use assemblies in fluid management processes within the biopharmaceutical industry. It requires manufacturers and stakeholders to adopt a risk-based approach, implement proper controls, and ensure the integrity and sterility of single-use systems.

cgmp compliant single-use technology

Meeting cGMP regulations with innovative single-use technologies

Manufacturers in the pharmaceutical industry are required to comply with cGMP (Current Good Manufacturing Practice). End-to-end solutions based on automated single-use technologies are an auspicious choice for drug substance manufacturers, given their many advantages. Their implementation in the manufacturing process promises efficiency, high product quality, cost reduction, and energy savings.

Annex 1: All you need to know

Annex 1: All you need to know

Annex 1 is a fundamental framework for the production of sterile medicinal goods. This article will provide an overview of the concept, its history, contents, challenges, and perspectives.

Annex 1 and the PUPSIT requirement

Annex 1 and the PUPSIT requirement

Annex 1 and PUPSIT meant significant changes in the pharmaceutical sector. In this article, we will illustrate the focus areas of Annex 1 and will discuss main aspects of PUPSIT.

  1. Current Good Manufacturing Practice (CGMP) Regulations, https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations, Published 01.03.2023
  2. The impact of cGMP compliance on consumer confidence in dietary supplement products, https://www.sciencedirect.com/science/article/abs/pii/S0300483X06000345?via%3Dihub, Published 01.03.2023
  3. Facts About the Current Good Manufacturing Practices (CGMPs), https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practices-cgmps, Published 01.03.2023
michael-muehlegger

Michael Mühlegger

Senior Director Marketing & Inside Sales

Michael Mühlegger is the Head of Marketing and Inside Sales at Single Use Support. He has 10+ years experience in the fields of marketing, inside sales, communications, content management, and creative production. With a keen understanding of market dynamics and customer behavior, Michael has successfully implemented innovative marketing strategies to drive business growth and enhance brand visibility.

He has a strong background in content management, with a focus on life sciences and biopharma trends, and is adept at creating compelling content across multiple platforms to engage audiences and effectively communicate brand messages.

 

More from Michael Mühlegger

mRNA & LNPs

Oligonucleotide manufacturing – challenges & solutions

Oligonucleotide manufacturing. Optimizing fluid management, freezing & cold storage | Purification Oligonucleotides

michael-muehlegger

Michael Mühlegger

October 25, 2024

mRNA & LNPs

Oligonucleotides simply explained

What are oligonucleotides? Nucleic acid types | RNA oligonucleotides | DNA oligos | Types of Oligonucleotides

michael-muehlegger

Michael Mühlegger

October 25, 2024

Read more about Single-use Technology

End-to-end Solution

Protein production and optimization strategies

Protein production is a crucial process that which a large variety of pharmaceutical products rely on. Therefore, we will discuss this procedure in this article, along with possibilities to improve it.


 

Khalil Essani - Single Use Support

Khalil Essani

April 9, 2024

Vaccines

What are Active Pharmaceutical Ingredients (APIs)?

Active Pharmaceutical Ingredients (APIs) are the cornerstone of pharmaceutical drugs, serving as the primary agents responsible for delivering therapeutic effects to patients. 

micheal-eder

Michael Eder

March 21, 2024

Single-use Technology

How to avoid single-use bag leakages in bioprocessing

Single-use bag leakage and the resulting product loss can cause delays in life-saving treatments, safety risks as well as financial loss. Therefore, this article will discuss aspects to consider in order to keep single-use bags safe and sound.

micheal-eder

Michael Eder

November 14, 2023

Single-use Technology

Bioprocess solutions: Advancements with single-use technology

Bioprocess manufacturing has seen remarkable advancements through the utilization of single-use technology. This shift in process development brings numerous advantages – in this article, we will cover some major advances.

michael-muehlegger

Michael Mühlegger

November 13, 2023